BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/26/2024 9:16:40 AM | Browse: 195 | Download: 809
 |
Received |
|
2024-08-06 02:42 |
|
Peer-Review Started |
|
2024-08-06 02:42 |
|
First Decision by Editorial Office Director |
|
2024-09-17 06:05 |
|
Return for Revision |
|
2024-09-17 06:05 |
|
Revised |
|
2024-09-21 08:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-11-06 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-11-06 07:08 |
|
Articles in Press |
|
2024-11-06 07:08 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-11-12 01:24 |
|
Publish the Manuscript Online |
|
2024-11-26 09:16 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Comparative breakthrough: Umbilical cord mesenchymal stem cells vs bone marrow mesenchymal stem cells in heart failure treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Peng Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National High Level Hospital Clinical Research Funding Project |
BJ-2023-206 |
|
| Corresponding Author |
Peng Li, MD, Department of Geriatics, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1 Dongdan, Dahua Road, Dongcheng District, Beijing 100730, China. lipbenzi@126.com |
| Key Words |
Mesenchymal stem cells; Heart failure; Umbilical cord-derived mesenchymal stem cells; Bone marrow-derived mesenchymal stem cells; Left ventricular ejection fraction; 6-minute walking distance; Cardiac regeneration therapy |
| Core Tip |
This article provides a comparative analysis of umbilical cord-derived mesenchymal stem cells (UC-MSCs) and bone marrow-derived mesenchymal stem cells (BM-MSCs) for the treatment of heart failure. UC-MSCs significantly increase left ventricular ejection fraction and exhibit a favorable safety profile, positioning them as a promising alternative to BM-MSCs. Future research should focus on optimizing administration protocols and understanding the long-term benefits of UC-MSCs in cardiac therapy. |
| Publish Date |
2024-11-26 09:16 |
| Citation |
Li P. Comparative breakthrough: Umbilical cord mesenchymal stem cells vs bone marrow mesenchymal stem cells in heart failure treatment. World J Cardiol 2024; 16(12): 776-780 |
| URL |
https://www.wjgnet.com/1949-8462/full/v16/i12/776.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v16.i12.776 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
